Article: DIGEST.(BUSINESS)

COLUMN: DIGEST

Biovest raises $8.5 million to pay debt

WORCESTER - Biovest International Inc., which is working on a therapeutic vaccine for non-Hodgkin's lymphoma, said yesterday it has raised $8.5 million from existing investors to fund analysis of vaccine test results and pay certain debt.

Valens Offshore SPV II Corp. and Valens U.S. SPV I LLC, investment funds associated with the Laurus hedge fund family based in New York City, provided the financing in exchange for two secured promissory notes that become due in June 2008. Biovest also granted the Valens funds royalties of 7 percent of worldwide net sales and license revenues from Biovest ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!